Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs
- PMID: 17695377
- DOI: 10.3171/JNS-07/08/0253
Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs
Abstract
Object: Prophylactic use of antiepileptic drugs (AEDs) in patients admitted with aneurysmal subarachnoid hemorrhage (SAH) is common practice; however, the impact of this treatment strategy on in-hospital complications and outcome has not been systematically studied. The goal in this study was twofold: first, to describe the prescribing pattern for AEDs in an international study population; and second, to delineate the impact of AEDs on in-hospital complications and outcome in patients with SAH.
Methods: The authors examined data collected in 3552 patients with SAH who were entered into four prospective, randomized, double-blind, placebo-controlled trials conducted in 162 neurosurgical centers and 21 countries between 1991 and 1997. The prevalence of AED use was assessed by study country and center. The impact of AEDs on in-hospital complications and outcome was evaluated using conditional logistic regressions comparing treated and untreated patients within the same study center.
Results: Antiepileptic drugs were used in 65.1% of patients and the prescribing pattern was mainly dependent on the treating physicians: the prevalence of AED use varied dramatically across study country and center (intraclass correlation coefficients 0.22 and 0.66, respectively [p < 0.001]). Other predictors included younger age, worse neurological grade, and lower systolic blood pressure on admission. After adjustment, patients treated with AEDs had odds ratios of 1.56 (95% confidence interval [CI] 1.16-2.10; p = 0.003) for worse outcome based on the Glasgow Outcome Scale; 1.87 (95% CI 1.43-2.44; p < 0.001) for cerebral vasospasm; 1.61 (95% CI 1.25-2.06; p < 0.001) for neurological deterioration; 1.33 (95% CI 1.01-1.74; p = 0.04) for cerebral infarction; and 1.36 (95% CI 1.03-1.80; p = 0.03) for elevated temperature during hospitalization.
Conclusions: Prophylactic AED treatment in patients with aneurysmal SAH is common, follows an arbitrary prescribing pattern, and is associated with increased in-hospital complications and worse outcome.
Comment in
-
Antiepileptic drugs and subarachnoid hemorrhage.J Neurosurg. 2007 Aug;107(2):251-2; discussion 252. doi: 10.3171/JNS-07/08/0251. J Neurosurg. 2007. PMID: 17695376 No abstract available.
Similar articles
-
Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage.Neurosurgery. 2007 Apr;60(4):658-67; discussion 667. doi: 10.1227/01.NEU.0000255396.23280.31. Neurosurgery. 2007. PMID: 17415202 Clinical Trial.
-
Use of Antiepileptic Drugs in Aneurysmal Subarachnoid Hemorrhage.Can J Neurol Sci. 2019 Jul;46(4):423-429. doi: 10.1017/cjn.2019.54. Epub 2019 May 22. Can J Neurol Sci. 2019. PMID: 31113497
-
National socioeconomic indicators are associated with outcomes after aneurysmal subarachnoid hemorrhage: a hierarchical mixed-effects analysis.J Neurosurg. 2014 Nov;121(5):1039-47. doi: 10.3171/2014.7.JNS132141. Epub 2014 Aug 15. J Neurosurg. 2014. PMID: 25127417 Clinical Trial.
-
Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.Rev Neurol Dis. 2008 Fall;5(4):178-81. Rev Neurol Dis. 2008. PMID: 19122570 Review.
-
Seizures and Choice of Antiepileptic Drugs Following Subarachnoid Hemorrhage: A Review.Can J Neurol Sci. 2017 Nov;44(6):643-653. doi: 10.1017/cjn.2017.206. Can J Neurol Sci. 2017. PMID: 29391074 Review.
Cited by
-
[Aneurysmal subarachnoid hemorrhage].Anaesthesist. 2012 Sep;61(9):792-814. doi: 10.1007/s00101-012-2077-2. Anaesthesist. 2012. PMID: 22955889 Review. German.
-
Diagnosis and management of subarachnoid haemorrhage.Nat Commun. 2024 Feb 29;15(1):1850. doi: 10.1038/s41467-024-46015-2. Nat Commun. 2024. PMID: 38424037 Free PMC article. Review.
-
Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.Neurocrit Care. 2009;10(1):141-7. doi: 10.1007/s12028-008-9147-y. Epub 2008 Sep 23. Neurocrit Care. 2009. PMID: 18810661
-
Duration and choices of prophylactic anticonvulsants in subarachnoid hemorrhage: a systematic review and meta-analysis.Neurosurg Rev. 2021 Oct;44(5):2459-2467. doi: 10.1007/s10143-020-01466-1. Epub 2021 Jan 3. Neurosurg Rev. 2021. PMID: 33389342
-
Seizures and Epilepsy following Aneurysmal Subarachnoid Hemorrhage : Incidence and Risk Factors.J Korean Neurosurg Soc. 2009 Aug;46(2):93-8. doi: 10.3340/jkns.2009.46.2.93. Epub 2009 Aug 31. J Korean Neurosurg Soc. 2009. PMID: 19763209 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical